Phase 1 study of Blu-285 in advanced systemic mastocytosis
0 Views
administrator
07/09/23
Prof DeAngelo presents, in a press conference at the ASH 2017 annual meeting, data from a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis.
Read the news story or watch the interview with Prof DeAngelo for more.
-
Category
Show more
Facebook Comments
No comments found